Essex Bio-Technology Ltd (1061.HK) reported earnings for its full year that Increased, from last year
The company's bottom line came in at HK$318.09 million, or HK$0.561 per share. This compares with HK$307.22 million, or HK$0.5318 per share, last year.
The company's revenue for the period rose 8.6% to HK$1.813 billion from HK$1.669 billion last year.
Essex Bio-Technology Ltd earnings at a glance (GAAP) :
-Earnings: HK$318.09 Mln. vs. HK$307.22 Mln. last year.-EPS: HK$0.561 vs. HK$0.5318 last year.-Revenue: HK$1.813 Bln vs. HK$1.669 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.